However, the authors note that substantial weight loss can be accompanied by reductions in lean body mass, underscoring the need for further research into dosing strategies and interventions that preserve muscle while promoting fat loss
Often yes, with coordination
Initially approved for the management of type 2 diabetes , semaglutide has expanded its indications significantly due to its profound effects on body weight and overall metabolic health
Semaglutide is a GLP-1 receptor agonist - a class of medications originally developed for type 2 diabetes that has been shown to produce significant weight loss
Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C, et al